Cardiorenal links in systemic amyloidosis
- 作者: Rameev VV1, Kozlovskaia LV1, Zhdanova EA1, Gudkova KV1
-
隶属关系:
- Первый МГМУ им. И.М. Сеченова Минздрава России
- 期: 卷 85, 编号 6 (2013)
- 页面: 51-59
- 栏目: Editorial
- URL: https://journal-vniispk.ru/0040-3660/article/view/31287
- ID: 31287
如何引用文章
全文:
详细
作者简介
V Rameev
Первый МГМУ им. И.М. Сеченова Минздрава России
Email: vvrameev@mtu-net.ru
L Kozlovskaia
Первый МГМУ им. И.М. Сеченова Минздрава России
E Zhdanova
Первый МГМУ им. И.М. Сеченова Минздрава России
K Gudkova
Первый МГМУ им. И.М. Сеченова Минздрава России
参考
- Виноградова О.М. Первичный и генетические варианты амилодоза. М 1980; 224.
- Pennell D.J., Maceira A.M. Magnetic Resonance Imaging in Cardiac Amyloidosis. J Am Coll Cardiol Img 2009; 2: 1378-1380.
- Cueto-Garcia L., Tajik A.J., Kyle R.A. et al. Serial echocardiographic observations in patients with primary systemic amyloidosis: an introduction to the concept of early (asymptomatic) amyloid infiltration of the heart. Mayo Clin Proc1984; 59 (9): 589-597.
- Shah K., Inoue Y., Mehra M. Amyloidosis and the heart: a comprehensive review. Arch Intern Med 2006; 166 (17): 1805-1813.
- Klein A.L., Hatle L.K., Taliercio C.P. et al. Serial Doppler echocardiographic follow-up of left ventricular diastolic function in cardiac amyloidosis J Am Coll Cardiol 1990; 16: 1135-1141.
- Demir M., Paydas S., Cayli M. et al. Tissue Doppler is a more reliable method in early detection of cardiac dysfunction in patients with AA amyloidosis. Ren Fail 2005; 27: 415-420.
- Klein A.L., Hatle L.K., Taliercio C.P. et al. Prognostic significance of Doppler measures of diastolic function in cardiac amyloidosis. A Doppler echocardiography study. Circulation 1991; 83: 808-816.
- Smedema J.-P., James R. Tissue Doppler imaging and contrast-enhanced cardiac magnetic resonance in primary cardiac amyloidosis. Eur J Echocardiogr 2009; 10: 984-986.
- Koyama J., Ray-Sequin P.A., Falk R.H. Longitudinal Myocardial Function Assessed by Tissue Velocity, Strain, and Strain Rate Tissue Doppler Echocardiography in Patients With AL (Primary) Cardiac Amyloidosis. Circulation 2003; 107: 2446-2452.
- Takemura G., Takatsu Y., Doyama K. et al. Expression of atrial and brain natriuretic peptides and their genes in hearts of patients with cardiac amyloidosis. J Am Coll Cardiol 1998; 31: 754-765.
- Rosenzweig M., Landau H. Light chain (AL) amyloidosis: update on diagnosis and management. Creative Commons Attribution License, 2011.
- Siqueira-Filho A.G., Cunha C.L., Tajik A.J. et al. M-mode and twodimensional echocardiographic features in cardiac amyloidosis. Circulation 1981; 63: 188-196.
- Dubrey S.W., Cha K., Anderson J. et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJM 1998; 91: 141-157.
- Ng B., Connors L.H., Davidoff R. et al. Senile systemic amyloidosis presenting with heart failure: a comparison with light chain-associated amyloidosis. Arch Intern Med 2005; 165: 1425-1429.
- Perugini E., Rapezzi C., Piva T. et al. Non-invasive evaluation of the myocardial substrate of cardiac amyloidosis by gadolinium cardiac magnetic resonance. Heart 2006; 92: 343-349.
- Rapezzi C., Merlini G., Quarta C.C. et al. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types. Circulation 2009; 120: 1203-1212.
补充文件
